Abstract. Magnetic nano-and microparticles have already found many important applications in various areas of biosciences, medicine, biotechnology, environmental technology etc. These smart materials exhibit different types of response to external magnetic field. In most cases they can be described as composite materials, where the magnetic properties are caused by the presence of iron oxides nano-or microparticles. Such materials can be efficiently separated from difficult-to-handle samples and targeted to the desired place, applied as contrast agents for magnetic resonance imaging, used to generate heat during exposure to alternating magnetic field or to modify biomolecules and biological structures.
Introduction
Nanocomposites are materials that are usually created by introducing appropriate nanoparticles (often referred to as filler) into a macroscopic sample material (often referred to as the matrix). The resulting nanocomposites may exhibit drastically changed properties. For example, polymer electrical and thermal conductivity can be substantially increased after addition of carbon nanotubes [1] . Other nanoparticulate additives may result in enhanced mechanical, optical or magnetic properties. Such materials are of great importance for new scientific and technological applications. Materials whose physical properties can be varied by application of external magnetic fields belong to a specific class of smart materials. The broad family of magnetic field-controllable materials includes ferrofluids (magnetic fluids), magnetorheological fluids, magnetic polymers, magnetic inorganic materials, magnetically modified biological structures, magnetic particles with bound biomolecules etc. In many cases magnetically responsive composite materials consist of small magnetic particles (most often formed by magnetite, maghemite or various ferrites), usually in the nanometer to micrometer range, dispersed in a polymer, biopolymer or inorganic matrix; alternatively magnetic particles can be adsorbed on the outer surface of diamagnetic particles [2, 3] . Magnetic particles can be incorporated into the polymer either randomly or in ordered structure. If a uniform magnetic field is applied to the reactive mixture during the cross-linking process, particle chains form and become locked into the elastomer. The resulting composites exhibit anisotropic properties [4, 5] . Different chemical routes for the synthesis of superparamagnetic iron oxide nanoparticles (classic synthesis by precipitation, high-temperature reactions, reactions in steric environments, sol-gel reactions, decomposition of organometallic precursors, polyol methods, etc.) and their use for the preparation of magnetically responsive composite materials have been reviewed recently [2] . In addition to synthetic magnetic nano-and microparticles, biologically produced magnetic particles (e.g., magnetosomes present in various magnetotactic bacteria) have been successfully used for biotechnology applications.
Magnetic nano-and microparticles are subjects of fundamental scientific interest, but recently they have already found many important applications in various areas of biosciences, medicine, biotechnology, environmental technology etc. In most cases magnetic composite particles, prepared from biocompatible synthetic polymers (e.g., polylactic acid, polyvinyl alcohol, polyethylene glycol, polystyrene), biopolymers (e.g., cellulose, chitosan, dextran, starch, agarose, alginate, albumin, whole egg white), silica or porous glass have been used. These particles can be efficiently separated from difficult-to-handle samples (e.g., suspensions or viscous solutions) and targeted to the desired place, used as contrast agents for magnetic resonance imaging, to generate heat during exposure to alternating magnetic field, to modify biomolecules and biological structures etc. Different areas of biosciences and biotechnology have already benefited from the application of biologically active compounds (antibodies, enzymes, lectins, nucleic acids, oligonucleotides, specific affinity ligands) immobilized to magnetic nano-and microparticles (e.g., immunomagnetic assays of target compounds, affinity separation of cells, cell organelles or molecules, molecular biology applications, magnetofection, etc.). Biocompatible and biodegradable magnetic materials have been used as contrast agents during magnetic resonance imaging, for magnetic drug targeting, magnetic fluid hyperthermia and detoxification of biological fluids. Magnetically responsive microbial cells or lignocellulose, useful for xenobiotics removal, have been prepared by ferrofluid modification of the starting materials [2, 5, 6] .
Both biosciences and nanotechnology can have enormous benefit from close mutual cooperation. This short review will show selected examples of bioapplications of magnetically responsive composite materials.
Immobilization and modification of biologically active compounds
Immobilisation of enzymes, antibodies, oligonucleotides and other biologically active compounds is a very important technique used in various areas of biosciences and biotechnology. Several covalent conjugation strategies using amine, hydroxyl, carboxyl, aldehyde, or thiol groups exposed on the surface of magnetic particles have been developed. Biologically active compounds immobilised on magnetic carriers can be removed from the system by using an external magnetic field, or can be targeted to the desired place. The immobilised compounds can be used to express their activities in a desired process (e.g., immobilised enzymes), or can be used as affinity ligands to capture or to modify the target molecules or cells (e.g., antibodies or their fragments, streptavidin, lectins, oligonucleotides, aptamers, oligo-and polysaccharides, metal chelate binding groups, etc.). Magnetic particles with immobilized antibodies form a basis of immunomagnetic procedures, especially used in microbiology and cell biology for selective capture of target cells. Magnetic particles with immobilized streptavidin are used for efficient binding of biotinylated compounds while particles with chelated nickel ions are used for separation of recombinant histidine tagged proteins.
For specific applications commercially available magnetic composite nano-and microparticles with covalently immobilized molecules (e.g., streptavidin, avidin, annexin V, different types of primary and secondary antibodies, protein A, protein G, pepsin, papain, oligonucleotides, biotin, nitrilotriacetic acid and some others) can be used. A wide variety of activated magnetic particles is available commercially enabling one-step immobilization process. Magnetic iron oxides nano-and microparticles activated with 3-aminopropyltriethoxysilane were used for the immobilisation of various enzymes, antibodies and protein A after glutaraldehyde treatment [5] .
Enzymes can be made soluble and active in organic solvents by chemical modification with the amphipathic macromolecule, polyethylene glycol (PEG). The PEG-enzyme conjugates can be also conjugated to magnetic nanoparticles. Alternatively, the magnetite-PEG conjugate is prepared first and then conjugated to the target enzyme. The magnetically modified enzymes stably disperse in both organic solvents and aqueous solutions. Magnetically modified lipase catalyses ester synthesis Solid State Phenomena Vol. 151 89 in organic solvents and can be easily recovered by magnetic force without loss of enzyme activity [5] .
Also magnetoliposomes, containing magnetic nanoparticles entrapped within the liposome cavity, have been used for immobilisation of membrane-bound enzymes, antibodies or for the entrapment of various drugs. The catalytic activity of isolated, lipid-depleted membrane-bound enzymes, such as cytochrom c-oxidase, has been substantially enhanced after their incorporation in magnetoliposomes [5] .
Isolation and separation of biologically active compounds, xenobiotics and cells
Isolation, separation and purification of various types of biomolecules (proteins, peptides, nucleic acids, nucleotides, oligo-and polysaccharides etc.), as well as of other specific molecules (low molecular weight biologically active compounds, xenobiotics, drugs, heavy metal ions, radionuclides etc.), cells and cell organelles is used in almost all branches of biosciences and biotechnologies. New separation techniques, capable of treating difficult-to-handle samples, are necessary. In this case magnetic affinity, ion exchange, hydrophobic or adsorption batch separation processes, use of magnetically responsive biocomposites, applications of magnetically stabilized fluidized beds or magnetically modified two-phase systems have shown their usefulness. This process is usually very simple, and in most cases all steps of the purification can take place in one test tube without expensive liquid chromatography systems; magnetic separation of magnetic microparticles can be performed in an extremely simple and inexpensive way using strong permanent magnets or commercial magnetic separators. Magnetic recovery of target compounds can also be performed from samples with extremely high viscosity; separation of lysozyme from native hen egg white with magnetic microporous cellulose cation exchangers can serve as an example [7] . Immunomagnetic separation (IMS) enables to separate highly purified populations of target prokaryotic and eukaryotic cells from complex samples; this process is gentle, can be easily scaled up and isolated cells are usually viable and unaltered. IMS also enables to detect the presence of important pathogenic bacteria (e.g., various strains of Salmonella, verotoxigenic strains of Escherichia coli or Listeria monocytogenes) and parasites (e.g., Cryptosporidium and Giardia) in food, clinical and water samples. Several extensive reviews are available covering e.g. proteins and peptides separation [8] [9] [10] , separation of nucleic acids [11, 12] or prokaryotic and eukaryotic cells separation [13, 14] .
Magnetic drug and radionuclide targeting
Drug and radionuclide targeting, i.e. predominant active compound accumulation in the body target zone independently on the method and route of drug administration, may resolve main problems currently associated with systemic drug administration. One of the possible schemes for drug targeting includes magnetic targeting. For this purpose, the drug or radionuclide can be immobilised in biocompatible magnetically responsive nano-or microspheres or in magnetoliposomes. Typically, the intended drug and an appropriate ferrofluid are formulated into a pharmaceutically stable formulation with the least amount of magnetic particles and maximum concentration of drug. It is then usually injected through the artery that supplies the target organ or tumour in the presence of an external magnetic field. Prolonged retention of the magnetic drug carrier at the target site alleviates, or delays the RES clearance and facilitates extravascular uptake. This process is based on competition between forces exerted on the particles by the macro-and microcirculation, the characteristics of the magnetic particles (size, configuration) and the applied magnetic field. To effectively retain the magnetic drug carrier, the magnetic forces must be high enough to counteract linear flow rates within the organ or tumour tissue (between 10 and 0.05 cm/s depending on the vessel size and branching patterns) [5, 15, 16] .
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Magnetic resonance imaging
Currently magnetic resonance imaging (MRI) belongs to standard medical examination methods. In MRI, image contrast is a result of the different signal intensity each tissue produces in response to a particular sequence of the applied radiofrequency pulses. This response is dependent on the proton density and magnetic relaxation times so as MRI contrast depends on the chemical composition (especially on the concentration of water or lipid molecules) and molecular structure of the tissue and is usually manipulated by adjusting the instrumental parameters. In order to increase the contrast between different tissues or a healthy/diseased tissue, target-specific superparamagnetic particles can serve as a dramatic source of exogenous contrast. Superparamagnetic biopolymer coated magnetite nanoparticles change the rate at which protons decay from their excited state to the ground state. As a result, regions containing the superparamagnetic contrast agent appear darker in an MRI than regions without the agent. For instance, when superparamagnetic iron oxides nanoparticles are delivered to the liver, healthy liver tissue can uptake the particles while the tumour tissue cannot, due to the absence of Kupfer cells. Consequently, the healthy regions are darkened, and the diseased regions remain bright [5] . Particulate magnetic contrast agents include ultrasmall particles (USPIO -ultra small particles of iron oxide, diameter between 10 and 40 nm), small particles (SPIO -small particles of iron oxide, diameter between 60 and 150 nm), and oral (large) particles (diameter between 300 nm and 3.5 µm). Commercially available iron oxides based contrast agents are usually stabilized by dextran, carboxymethyl dextran, carboxydextran or styrenedivinylbenzene copolymer [2] .
Cellular magnetic resonance imaging (CMRI) is a rapidly growing field that aims to visualize and track cells in living organisms. Ex vivo labelling of studied cells with biocompatible superparamagnetic iron oxide nanoparticles allows for the detection of single cells or clusters of labelled cells within target tissues and organs using CMRI following either direct implantation or intravenous injection [17, 18] .
Magnetic fluid hyperthermia
Hyperthermia is a promising approach to cancer therapy based on the heating of the target tissue to the temperatures between 42 and 46 ºC that generally reduces the viability of cancer cells and increases their sensitivity to chemotherapy and radiation. Unlike chemotherapy and radiotherapy, hyperthermia itself has fewer side effects. Magnetic fluid hyperthermia is based on the fact that subdomain biocompatible magnetic particles produce heat through various kinds of energy losses during application of external AC magnetic field. If magnetic particles can be accumulated only in the tumour tissue, cancer specific heating is available.
Different types of magnetic biocompatible nanocomposites such as dextran stabilized magnetic fluid, other types of biocompatible magnetic fluids, aminosilan-modified nanoparticles, cationic magnetoliposomes or affinity magnetoliposomes have been used for hyperthermia treatment. Several review papers are available on this topic [5, 19, 20 ].
An interesting possibility of cancer treatment is the combination of hyperthermia treatment followed by chemotherapy or gene therapy. In this case magnetic nano-or microparticles containing a drug are first used to cause hyperthermia using the standard procedure, and then the released drug acts on the injured cancer cells. Magnetoliposomes may be especially useful for this purpose, because irradiation by an oscillating magnetic field will allow to reach the phase transition temperature of the membrane followed by rapid and massive drug release [2, 21] .
Magnetic composite particles for bioassays
Magnetic modifications of standard immunoassays can be successfully used for the determination of various biologically active compounds and xenobiotics. In these techniques specific antibodies or antigens are covalently immobilised on fine magnetic particles. Magnetically based assays are usually faster and more reproducible than the standard microtitration plate based assays and have proven to be simple, rapid and sensitive. The detection systems can be based on the use of enzymes, radioisotopes, fluorescent substances or chemiluminescence. The possibility of automation of the analytical procedures is especially important. On the other hand, magnetic immunoassays can be used for field measurements, such as in the case of pesticides, polyaromatic hydrocarbons or TNT determination in water and soil.
Alternative immunoassays or assays employing other binding molecules (e.g., lectins or aptamers) can employ magnetic nanoparticles as ferromagnetic labels (instead of enzymes, radionuclides etc.). After binding the labelled antibody or lectin to the target analyte the magnetically labelled complex can be captured by larger particles with immobilised specific antibodies against another analyte epitope and after sedimentation the amount of magnetically labelled analyte in the sedimented fraction is measured with an appropriate transducer (e.g., magnetic permeability meter). The possible advantage of this approach includes very low interference from the sample matrix, as the transducer is only sensitive to ferromagnetic substances, which rarely are present in the biological samples [5] .
Currently new types of very sensitive sensors and biochips employing e.g. giant magnetoresistance are under development. These systems allow detection of low amounts of magnetic nano-and microparticles (serving as biomolecular or cellular labels) and thus enable to detect extremely low amounts of target analytes [22] [23] [24] .
Magnetofection
Magnetofection is nucleic acid delivery to cells supported and site-specifically guided by the attractive forces of magnetic fields acting on nucleic acid molecules which are associated with magnetic nanoparticles. The fundamental principle of magnetofection is simple and comprises the steps of formulating a magnetic vector, its addition to the medium covering cultured cells and applying a magnetic field in order to direct the vector towards the target cells. The simplest approach to form magnetic derivatives of nucleic acids employs magnetic nanocomposites covered with charged biocompatible polymers which enable formation of ionic complexes. Magnetically guided nucleic acid delivery can be practiced with viral and synthetic nucleic acid vectors, and can be used to overexpress nucleic acids or to silence endogenous gene expression. It can improve the efficacy of nucleic acid delivery by concentrating and/or retaining an applied vector dose both in primary cells in culture as well as in explanted tissue specimens and in living animals. Magnetofection is a powerful tool in research and therapy [25] .
Magnetically responsive biological structures
An absolute majority of prokaryotic and eukaryotic cells is diamagnetic (i.e., without magnetic properties). In order to prepare magnetically responsive cells, the native cells have to be magnetically modified, usually by forming complexes with magnetic nano-and microparticles.
Generally the cells can be modified by the non-specific attachment of magnetic nanoparticles (e.g., by the magnetic fluid treatment), by binding of maghemite or magnetite particles on the cell surface, by specific interactions with immunomagnetic nano-and microparticles, by the biologically driven precipitation of paramagnetic compounds on the cell surface, by covalent immobilization on magnetic carriers, by cross-linking of the cells or isolated cell walls with a bifunctional reagent in the presence of magnetic particles or by entrapment (together with magnetic particles) into Magnetically responsive microbial cells (e.g., Saccharomyces cerevisiae, Kluyveromyces fragilis, Chlorella vulgaris, Pseudomonas putida) have been mainly used for the adsorption of both inorganic and organic xenobiotics, such as heavy metal ions, pesticides and water soluble dyes [3, 6] .
Other inexpensive biological materials, such as lignocellulose particles (sawdust) have been magnetically modified with water-based ferrofluid and the resulting material was used for dyes removal [27] .
Due to the low price of biological components (in selected cases waste microbial biomass can be used) and the simplicity of magnetic modification these types of magnetically responsive biocomposites can be considered for possible large scale applications in biotechnology and environmental technology.
Perspectives
Magnetic nano-and microcomposites represent very useful and widely used smart materials exhibiting several types of response during the application of external magnetic field (e.g., selective separation and targeting, heat production or increase of contrast during MRI). Enormous amount of bioapplications (both in vivo and in vitro) has already been described. A close integration of magnetic nano-and micromaterials into the existing and new biodisciplines and biotechnology processes is necessary.
However, new tasks have to be solved in the near future. Further study is necessary in order to prepare high quality magnetic nanoparticles in large scale without any laborious purification step to ensure their cost effective synthetic procedures. Extremely inexpensive magnetically responsive microparticles for large scale biotechnology applications (e.g., separation of biologically active compounds from fermentation media and agricultural wastes), as well as for environmental technology applications (e.g., removal of organic and inorganic xenobiotics) are necessary. In vivo and analytical applications require specific magnetic particles covered by appropriate biocompatible molecules in a precisely predefined way (quantity, orientation, geometric arrangement); the coating has also to improve the stability of magnetic nanoparticles and to prevent their aggregation. Such materials will enable to prepare stable injectable solutions necessary for potential medical applications. Safety and biocompatibility studies, in particular long-term toxicity studies, have to be carried out in a regular way [2] .
The combination of nanotechnologies and biosciences can bring many new results and open new areas in science and technology. Magnetic nano-and microcomposite materials will play an important role in this process.
